We are live on ! Find out more
REVH

Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock

Delisted

REVH was delisted on the 6th of December, 2022.

68 hedge funds and large institutions have $477M invested in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

13% more capital invested

Capital invested by funds: $421M → $477M (+$55.9M)

0% more funds holding

Funds holding: 6868 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

Holders
68
Holders Change
Holders Change %
0%
% of All Funds
1.15%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
18
Reduced
9
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RIA
26
RP Investment Advisors
Ontario, Canada
$4.76M +$635K +64,927 +15%
AA
27
AQR Arbitrage
Connecticut
$4.74M +$846K +86,479 +22%
CIM
28
Cowen Investment Management
New York
$4.15M +$4.16M +425,000 New
SCM
29
Saba Capital Management
New York
$3.84M +$2.07M +211,842 +117%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$3.81M
PAMP
31
Polar Asset Management Partners
Ontario, Canada
$3.08M -$1.96M -200,422 -39%
Bank of Nova Scotia
32
Bank of Nova Scotia
Ontario, Canada
$2.93M
BCM
33
Basso Capital Management
Connecticut
$2.44M
PMAM
34
Picton Mahoney Asset Management
Ontario, Canada
$2.44M
CL
35
CSS LLC
Illinois
$2.27M -$249K -25,497 -10%
GCM
36
Ghisallo Capital Management
Massachusetts
$2.2M
Nomura Holdings
37
Nomura Holdings
Japan
$1.97M
TCM
38
Tenor Capital Management
New York
$1.95M
TCA
39
Taconic Capital Advisors
New York
$1.95M
Parallax Volatility Advisers
40
Parallax Volatility Advisers
California
$1.71M +$1.71M +175,017 New
FTCM
41
First Trust Capital Management
Illinois
$1.38M +$1.38M +141,594 New
PCM
42
Prelude Capital Management
New York
$1.28M -$718K -73,393 -36%
MC
43
Meteora Capital
Florida
$1.09M +$115K +11,735 +12%
LA
44
Linden Advisors
New York
$1.07M -$16.5M -1,690,461 -94%
CCA
45
Castle Creek Arbitrage
Colorado
$996K
AGC
46
Angelo Gordon & Co
New York
$977K
Hudson Bay Capital Management
47
Hudson Bay Capital Management
Connecticut
$976K
Janus Henderson Group
48
Janus Henderson Group
United Kingdom
$492K -$215 -22 -0%
DCM
49
Dupont Capital Management
Delaware
$488K
Goldman Sachs
50
Goldman Sachs
New York
$448K

REVH Hedge Fund Activity: Q2 2022 in Review

68 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) for Q2 2022, worth a combined $477M — up 13% from $421M a quarter earlier.

Fund positioning in REVH was balanced in Q2 2022: 10 funds opened new positions, 10 closed out, 18 added to existing stakes and 9 trimmed.

The largest buyer was HGC Investment Management, adding an estimated $37.1M. The largest seller was Finepoint Capital, exiting entirely with an estimated $21.2M sold.

  • 68 institutional investors held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $477M of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock stock for Q2 2022, up 13% quarter-over-quarter.
  • 10 funds opened new Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock positions in Q2 2022 and 10 closed out, a net change of 0 holders.
  • The largest Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock buyer in Q2 2022 was HGC Investment Management, an estimated $37.1M added.
  • The largest Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock seller in Q2 2022 was Finepoint Capital, an estimated $21.2M sold.

Based on aggregated 13F filings for Q2 2022.